Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 115 |
| Active Pipeline (Recruiting Now) | 63 (37) |
| Completed vs Stopped Early | 32 / 16 (13.9%) |
| Median Closed Actual Enrollment | 31 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora, CO | 77 |
| Children's Hospital Colorado | Aurora, CO | 9 |
| Oregon Health and Science University Knight Cancer Institute | Portland, OR | 3 |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for UCHealth / University of Colorado across sibling Meru public-data platforms.
Explore interactive annual charts and M&A subsidiary rollups in the University of Colorado, Denver Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.